Sleep and Nocturnal Endocrine Function in MDMA User
Sleep and Nocturnal Endocrine Function in MDMA User
批准号:
7261704
负责人:
UNA D MCCANN
金额:
$39.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-30 至 2008-07-31
关键词:
3,4 methylenedioxymethamphetamineage differencebehavioral /social science research tagbioperiodicityblood chemistryclinical researchcortisoldopaminedrug abusedrug addictionelectroencephalographyendocrine disorderenzyme linked immunosorbent assaygender differencehormone biosynthesishuman subjectinterviewneuropsychological testsneurotoxicologypolysomnographyprolactinradioimmunoassayserotoninsleep disorderssomatotropinurinalysis
中文摘要
描述(由申请人提供):(+/-)3,4-亚甲基二氧基甲基苯丙胺(MDMA,“摇头丸”)是一种越来越受欢迎的滥用精神活性药物,已被证明是一种在动物中有效的脑5-羟色胺(5-HT)神经毒素。在娱乐MDMA使用者中,越来越多的证据表明,MDMA也可以导致人类的5-羟色胺损伤。最近在非人类灵长类动物中的数据表明,一些使用MDMA的人(即那些“狂欢”使用MDMA的人)也可能引起脑多巴胺(DA)神经毒性,尽管尚未进行临床研究来测试这种可能性。MDMA对人类的神经毒性的功能后果一直很难确定。然而,几项研究表明,以前接触MDMA的人的睡眠模式和内分泌功能发生了变化。由于5-羟色胺和多巴胺参与了睡眠和内分泌功能的调节,MDMA使用者睡眠和内分泌功能的改变可能与MDMA引起的5-羟色胺和/或DA神经毒性有关。此外,由于睡眠和昼夜节律影响激素分泌(反之亦然),MDMA使用者的睡眠和内分泌功能异常可能是相互关联的。这些研究旨在扩展以前对MDMA使用者的睡眠和神经内分泌功能的研究,并探索MDMA使用者和匹配对照组的睡眠和夜间神经内分泌功能之间的可能相互关系。该项目的具体目标是:1)使用标准的多导睡眠图和频谱功率法分析两组MDMA使用者和两组匹配的对照组受试者的睡眠模式。一组服用MDMA的人将是“暴饮者”,而第二组将报告从未在每12小时内服用超过剂量的MDMA。其中一组控制组将与非摇头丸吸毒者配对(除其他人口统计变量外),而第二组控制组将没有非法药物滥用史。2)研究受睡眠影响的5-羟色胺和/或多巴胺调节的催乳素、生长激素和皮质醇的夜间分泌模式;3)在影响内分泌的环境和认知因素最小的情况下,在睡眠期间用间氯苯基哌嗪(m-CPP)对男性和女性MDMA使用者进行5-羟色胺药理学挑战。拟议的研究结果将有助于更好地确定接触MDMA对人类的功能影响,并可能阐明5-羟色胺和多巴胺在睡眠和夜间内分泌功能中的作用。
英文摘要
DESCRIPTION (provided by applicant): (+/-) 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") is an increasingly popular psychoactive drug of abuse that has been shown to be a potent brain serotonin (5-HT) neurotoxin in animals. Growing evidence in recreational MDMA users indicates that MDMA can also lead to 5-HT damage in humans. Recent data in non-human primates suggests that some MDMA users (i.e., those who use MDMA in a "binge" regimen) may also incur brain dopamine (DA) neurotoxicity, although clinical studies to test this possibility have not yet been conducted. Functional consequences of MDMA neurotoxicity in humans have been difficult to identify. However, several studies have demonstrated altered sleep patterns and endocrine function in individuals previously exposed to MDMA. Since 5-HT and DA are involved in the regulation of sleep and endocrine function, it is possible that altered sleep and endocrine function in MDMA users is related to MDMA-induced 5-HT and/or DA neurotoxicity. Further, since sleep and circadian rhythms influence hormonal secretion (and vice versa), abnormalities of sleep and endocrine function in MDMA users may be inter-related. The proposed studies are intended to extend previous studies of sleep and neuroendocrine function in MDMA users, and explore possible interrelations between sleep and nocturnal neuroendocrine function in MDMA users and matched controls. The specific aims of the project are: 1) To analyze sleep patterns of 2 groups of MDMA users and 2 groups of matched control subjects using standard polysomnographic and spectral power methods. One group of MDMA users will be "bingers," whereas the second group will report never having taken more than dose of MDMA dose per 12-hour period. One control group will be matched with MDMA users for non-MDMA drug use (in addition to other demographic variables) whereas the second group of controls will have no history of illicit drug abuse. 2) To characterize the nocturnal secretion patterns of prolactin, growth hormone, and cortisol, three hormones that are modulated by 5-HT and/or DA influenced by sleep; and 3) To conduct 5-HT pharmacological challenges with m-chlorophenylpiperazine (m-CPP) in male and female MDMA users during sleep, when environmental and cognitive factors that can influence endocrine secretion are minimal. Results from the proposed studies will help better define the functional consequences of MDMA exposure in humans, and could shed light on the roles of 5-HT and DA in sleep and nocturnal endocrine function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PET Studies of the SERT and DAT in METH Users
-
批准号:8104233
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2010
-
负责人:UNA D MCCANN
-
依托单位:
PET Studies of the SERT and DAT in METH Users
-
批准号:8447112
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2010
-
负责人:UNA D MCCANN
-
依托单位:
PET Studies of the SERT and DAT in METH Users
-
批准号:8255635
-
项目类别:
-
资助金额:$36.94万
-
财政年份:2010
-
负责人:UNA D MCCANN
-
依托单位:
NEUROIMAGING MDMA NEUROTOXICITY: DOPAMINE STUDIES
-
批准号:7607459
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2006
-
负责人:UNA D MCCANN
-
依托单位:
SLEEP AND NOCTURNAL ENDOCRINE FUNCTION IN MDMA USERS
-
批准号:7607470
-
项目类别:
-
资助金额:$2.15万
-
财政年份:2006
-
负责人:UNA D MCCANN
-
依托单位:
PET STUDIES OF THE DOPAMINE TRANSPORTER IN ADULT ADHD
-
批准号:7607487
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2006
-
负责人:UNA D MCCANN
-
依托单位:
NEUROIMAGING MDMA NEUROTOXICITY: DOPAMINE STUDIES
-
批准号:7375813
-
项目类别:
-
资助金额:$1.06万
-
财政年份:2005
-
负责人:UNA D MCCANN
-
依托单位:
PET STUDIES OF THE DOPAMINE TRANSPORTER IN ADULT ADHD
-
批准号:7375844
-
项目类别:
-
资助金额:$0.41万
-
财政年份:2005
-
负责人:UNA D MCCANN
-
依托单位:
SLEEP AND NOCTURNAL ENDOCRINE FUNCTION IN MDMA USERS
-
批准号:7375825
-
项目类别:
-
资助金额:$13.25万
-
财政年份:2005
-
负责人:UNA D MCCANN
-
依托单位:
NEUROIMAGING MDMA NEUROTOXICITY: DOPAMINE STUDIES
-
批准号:7204448
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2004
-
负责人:UNA D MCCANN
-
依托单位:
SLEEP AND NOCTURNAL ENDOCRINE FUNCTION IN MDMA USERS
-
批准号:7204460
-
项目类别:
-
资助金额:$2.16万
-
财政年份:2004
-
负责人:UNA D MCCANN
-
依托单位:
Sleep and Nocturnal Endocrine Function in MDMA User
-
批准号:6733339
-
项目类别:
-
资助金额:$40.29万
-
财政年份:2003
-
负责人:UNA D MCCANN
-
依托单位:
Sleep and Nocturnal Endocrine Function in MDMA User
-
批准号:7274825
-
项目类别:
-
资助金额:$38.15万
-
财政年份:2003
-
负责人:UNA D MCCANN
-
依托单位:
Sleep and Nocturnal Endocrine Function in MDMA User
-
批准号:6806976
-
项目类别:
-
资助金额:$40.27万
-
财政年份:2003
-
负责人:UNA D MCCANN
-
依托单位:
PET Imaging MDMA Neurotoxicity
-
批准号:6582065
-
项目类别:
-
资助金额:$44.91万
-
财政年份:1995
-
负责人:UNA D MCCANN
-
依托单位:
PET Imaging MDMA Neurotoxicity
-
批准号:6806523
-
项目类别:
-
资助金额:$49.45万
-
财政年份:1995
-
负责人:UNA D MCCANN
-
依托单位:
PET Imaging MDMA Neurotoxicity
-
批准号:7097984
-
项目类别:
-
资助金额:$51.23万
-
财政年份:1995
-
负责人:UNA D MCCANN
-
依托单位:
PET Imaging MDMA Neurotoxicity
-
批准号:6905503
-
项目类别:
-
资助金额:$50.93万
-
财政年份:1995
-
负责人:UNA D MCCANN
-
依托单位:
PET Imaging MDMA Neurotoxicity
-
批准号:6665429
-
项目类别:
-
资助金额:$48.01万
-
财政年份:1995
-
负责人:UNA D MCCANN
-
依托单位:
海外基金